Skip to content

Clinical trials

Oropharyngeal Neoplasms trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Oropharyngeal Neoplasms Phase: Not applicable Country / region: United States Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20072
20082
20091
20102
20112
20122
20131
20142
20153
20162
20173
20186
20193
20202
20213
20232
20241
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting8
Terminated6
Active, not recruiting4
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Mayo Clinic3
UNC Lineberger Comprehensive Cancer Center3
Abramson Cancer Center at Penn Medicine2
Georgetown University2
H. Lee Moffitt Cancer Center and Research Institute2
University of Miami2
University of Wisconsin, Milwaukee2
Wake Forest University Health Sciences2
Boston Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Oropharyngeal Neoplasms47
Head and Neck Neoplasms22
Laryngeal Neoplasms16
Mouth Neoplasms16
Hypopharyngeal Neoplasms14
Nasopharyngeal Neoplasms8
Squamous Cell Carcinoma of Head and Neck6
Lung Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Uterine Cervical Neoplasms4

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.